Cargando…
Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis
Background: Anti-inflammatory therapy has been proposed as a promising treatment for coronary heart disease (CHD) that could reduce residual inflammation risk (RIR) and therefore major adverse cardiovascular events. We implemented a systematic review and meta-analysis of randomized controlled trials...
Autores principales: | Wang, Haiming, Jiang, Min, Li, Xin, Zhao, Yunzhang, Shao, Junjie, Liu, Zifan, Lin, Lejian, Xu, Qiang, Wang, Lin, Lu, Xuechun, Zhang, Haomin, Chen, Yundai, Zhang, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424052/ https://www.ncbi.nlm.nih.gov/pubmed/34513960 http://dx.doi.org/10.3389/fcvm.2021.726341 |
Ejemplares similares
-
Potential of immune-related genes as promising biomarkers for premature coronary heart disease through high throughput sequencing and integrated bioinformatics analysis
por: Wang, Haiming, et al.
Publicado: (2022) -
Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications
por: Wang, Haiming, et al.
Publicado: (2020) -
Pathogenesis of premature coronary artery disease: Focus on risk factors and genetic variants
por: Wang, Haiming, et al.
Publicado: (2020) -
Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease
por: Zhang, Yingyue, et al.
Publicado: (2021) -
Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of 1990–2022
por: Zhang, Jiale, et al.
Publicado: (2023)